Patients without conventional modifiable risk factors (SMuRFless) presenting with obstructive myocardial infarction face a significantly higher 30-day mortality
Growth differentiation factor 15 and all-cause and cause-specific mortality in patients with suspected or known coronary artery disease: The ANOX and EXCEED-J Studies
Lipoprotein(a) levels above 70 mg/dL are an independent predictor for long-term major adverse cardiovascular events in patients with premature (<40 years) acute coronary syndrome